Ryan Merkow to Imatinib Mesylate
This is a "connection" page, showing publications Ryan Merkow has written about Imatinib Mesylate.
Connection Strength
0.024
-
Incorporation of adjuvant therapy into the multimodality management of gastrointestinal stromal tumors of the stomach in the United States. Ann Surg Oncol. 2012 Jan; 19(1):184-91.
Score: 0.024